HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Buijs, W. C.A.M. Articles by Corstens, F. H.M. Search for Related Content PubMed PubMed Citation Articles by Buijs, W. C.A.M. Articles by Corstens, F. H.M.

Absolute Organ Activity Estimated by Five Different Methods of Background Correction

University Hospital Nijmegen, Department of Nuclear Medicine, University of Nijmegen, The Netherlands

Correspondence: For correspondence or reprints contact: Wilhelmina C.A.M. Buijs, PhD, Department of Nuclear Medicine, University Hospital Nijmegen, 6500 HB Nijmegen, The Netherlands.

ABSTRACT

Accurate absorbed dose estimates in radionuclide therapy require patient-specific dosimetry. In patient-based dosimetry, estimation of absolute organ uptake is essential. The methods used should be reasonably accurate as well as easy to perform in routine clinical practice. One of the major sources of uncertainty in quantification of organ or tumor activity from planar images is the activity present in the tissue surrounding the source. Methods: To estimate organ activity as a function of organ-to-background activity concentration ratio, a cylindrical phantom, filled with 5.6 liters of water was used to simulate the abdomen of a patient. Two other cylinders of 150 ml each, representing the kidneys, were each filled with 19 MBq ^99mTc and were positioned in the abdomen phantom. The phantom was imaged with a dual-head gamma camera with the kidneys placed at posterior depths of 1-, 5- and 10-cm at kidney-to-background activity concentration ratios of infinity, 10:1, 5:1 and 2:1. The conjugate view geometric mean counting method was used to quantify activity. Five methods for background correction were applied: (1) no correction; (2) conventional background correction (simple subtraction of the background counting rate from the source region counting rate); (3) Kojima method (background corrected for organ thickness and depth); (4) Thomas method (analytical solution); and (5) Buijs method (background corrected for organ and total-body thickness). Results: Since the results were identical for both kid neys, only the left kidney activity measurements are presented. The accuracy of the five background correction methods is given as the percentage difference between the actual and measured activity in the left kidney. For Method 1, the percentage difference ranged from –2% with an infinite kidney-to-background activity concentration ratio to +413% with a 2:1 ratio. For Method 2, these values ranged from –1% to –80%, for Method 3 from +11% to –18%, for Method 4 from –2% to +120% and for Method 5 from –4% to +39%. Conclusion: Even though quantitative SPECT is the most rigorous method for activity quantification in conditions of low organ-to-background activity concentration ratio, planar scintigraphy can be applied accurately if appropriate attention is paid to background correction. Using relatively simple background subtraction methods, the quantitative planar imaging technique can result in reasonably accurate activity estimates (Methods 3 and 5).The use of Kojima's method is preferable, especially at very low source-tobackground activity concentration ratios.

Key Words: background correction • quantitative planar imaging • absolute organ activity

This article has been cited by other articles:

				C. P. Bleeker-Rovers, H. J.J.M. Rennen, O. C. Boerman, A. B. Wymenga, E. P. Visser, J. H. Bakker, J. W.M. van der Meer, F. H.M. Corstens, and W. J.G. Oyen 99mTc-Labeled Interleukin 8 for the Scintigraphic Detection of Infection and Inflammation: First Clinical Evaluation J. Nucl. Med., March 1, 2007; 48(3): 337 - 343. [Abstract] [Full Text] [PDF]

				Y.-C. Ma, L. Zuo, C.-L. Zhang, M. Wang, R.-F. Wang, and H.-Y. Wang Comparison of 99mTc-DTPA renal dynamic imaging with modified MDRD equation for glomerular filtration rate estimation in Chinese patients in different stages of chronic kidney disease Nephrol. Dial. Transplant., February 1, 2007; 22(2): 417 - 423. [Abstract] [Full Text] [PDF]

				E. Vegt, J. F.M. Wetzels, F. G.M. Russel, R. Masereeuw, O. C. Boerman, J. E. van Eerd, F. H.M. Corstens, and W. J.G. Oyen Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin J. Nucl. Med., March 1, 2006; 47(3): 432 - 436. [Abstract] [Full Text] [PDF]

				L. Jonsson, M. Ljungberg, and S.-E. Strand Evaluation of Accuracy in Activity Calculations for the Conjugate View Method from Monte Carlo Simulated Scintillation Camera Images Using Experimental Data in an Anthropomorphic Phantom J. Nucl. Med., October 1, 2005; 46(10): 1679 - 1686. [Abstract] [Full Text] [PDF]

				A. H. Brouwers, W. C.A.M. Buijs, P. F.A. Mulders, P. H.M. de Mulder, W. J.M. van den Broek, C. Mala, E. Oosterwijk, O. C. Boerman, F. H.M. Corstens, and W. J.G. Oyen Radioimmunotherapy with [131I]cG250 in Patients with Metastasized Renal Cell Cancer: Dosimetric Analysis and Immunologic Response Clin. Cancer Res., October 1, 2005; 11(19): 7178s - 7186s. [Abstract] [Full Text] [PDF]

				E. J. Postema, P. K.E. Borjesson, W. C.A.M. Buijs, J. C. Roos, H. A.M. Marres, O. C. Boerman, R. de Bree, M. Lang, G. Munzert, G. A.M.S. van Dongen, et al. Dosimetric Analysis of Radioimmunotherapy with 186Re-Labeled Bivatuzumab in Patients with Head and Neck Cancer J. Nucl. Med., October 1, 2003; 44(10): 1690 - 1699. [Abstract] [Full Text] [PDF]

				A. H. Brouwers, W. C. A. M. Buijs, E. Oosterwijk, O. C. Boerman, C. Mala, P. H. M. De Mulder, F. H. M. Corstens, P. F. A. Mulders, and W. J. G. Oyen Targeting of Metastatic Renal Cell Carcinoma with the Chimeric Monoclonal Antibody G250 Labeled with 131I or 111In: An Intrapatient Comparison Clin. Cancer Res., September 1, 2003; 9(10): 3953S - 3960. [Abstract] [Full Text] [PDF]

				G. J. Kemerink, X. Liu, D. Kieffer, S. Ceyssens, L. Mortelmans, A. M. Verbruggen, N. D. Steinmetz, J.-L. Vanderheyden, A. M. Green, and K. Verbeke Safety, Biodistribution, and Dosimetry of 99mTc-HYNIC-Annexin V, a Novel Human Recombinant Annexin V for Human Application J. Nucl. Med., June 1, 2003; 44(6): 947 - 952. [Abstract] [Full Text] [PDF]

				K. Sjogreen, M. Ljungberg, and S.-E. Strand An Activity Quantification Method Based on Registration of CT and Whole-Body Scintillation Camera Images, with Application to 131I J. Nucl. Med., July 1, 2002; 43(7): 972 - 982. [Abstract] [Full Text] [PDF]

				G. J. Kemerink, I. H. Liem, L. Hofstra, H. H. Boersma, W. C.A.M. Buijs, C. P.M. Reutelingsperger, and G. A.K. Heidendal Patient Dosimetry of Intravenously Administered 99mTc-Annexin V J. Nucl. Med., February 1, 2001; 42(2): 382 - 387. [Abstract] [Full Text]

				D. R. Colnot, J. J. Quak, J. C. Roos, A. van Lingen, A. J. Wilhelm, G. J. van Kamp, P. C. Huijgens, G. B. Snow, and G. A.M.S. van Dongen Phase I Therapy Study of 186Re-Labeled Chimeric Monoclonal Antibody U36 in Patients with Squamous Cell Carcinoma of the Head and Neck J. Nucl. Med., December 1, 2000; 41(12): 1999 - 2010. [Abstract] [Full Text] [PDF]